How to Design an Effective sgRNA?

Designing an effective sgRNA (single-guide RNA) is a critical step in CRISPR/Cas9-mediated genome editing. To achieve efficient and specific genome editing, sgRNA design should follow a systematic set of design principles and workflow.

I. sgRNA Design Principles

1. Length and Sequence Composition

1. For Type II CRISPR systems such as SpCas9, the target sequence of an sgRNA is typically 20 nucleotides (nt) in length.

2. The sgRNA target sequence should generally avoid ending with four or more consecutive thymine (T) residues, which may cause premature termination when sgRNA expression is driven by certain RNA polymerase III promoters. A GC content of approximately 30%–70% is generally recommended to balance target binding and sgRNA activity.

2. PAM Sequence

The target sequence must be immediately adjacent to an appropriate PAM (protospacer adjacent motif). For SpCas9, the canonical PAM is NGG, where N can be any nucleotide.

The PAM is essential for Cas9 recognition and DNA cleavage. Importantly, the PAM itself is not part of the sgRNA target sequence.

3. Specificity

1. The sgRNA target sequence should be highly specific to the gene of interest and should minimize potential matches elsewhere in the genome to reduce off-target effects.

2. Bioinformatics tools can be used to perform genome-wide off-target analysis and identify candidate sgRNAs with high predicted specificity and minimal potential off-target sites.

4. Transcription Efficiency

When sgRNA expression is driven by U6 or H1 promoters, it is generally preferable for the sgRNA transcript to begin with G, or sometimes GG, because RNA polymerase III promoters such as U6 often show improved transcription when the first nucleotide is G.

5. Target Region Selection

For experiments designed to generate frameshift mutations and gene knockouts, sgRNAs are typically designed within the coding sequence (CDS).

Targeting an early coding region—often toward the N-terminal portion of the coding sequence—can increase the likelihood that an indel will disrupt the open reading frame and substantially impair protein function. Targeting an early exon can therefore be advantageous, provided that the exon is shared by the relevant transcript isoforms.

6. Handling Multiple Transcript Isoforms

When a gene has multiple transcript isoforms, sgRNAs should preferably target a region shared by the major or relevant transcripts if the goal is to disrupt all isoforms.

If isoform-specific editing is desired, the sgRNA should instead target an exon or sequence unique to the transcript of interest.

II. sgRNA Design Workflow

1. Retrieve Target Gene Information

Use databases such as NCBI or Ensembl to obtain basic information about the target gene, including:

• Gene and transcript sequences

• Transcript isoforms

• Exon and intron positions

• Coding sequence (CDS)

• Relevant transcript annotations

Carefully verify the transcript and genome assembly before designing sgRNAs.

2. Select the Editing Region

Select an appropriate region according to the experimental objective.

For gene knockout experiments, early coding regions are commonly considered as candidate target regions. However, the specific target should be selected based on transcript structure, functional domains, isoforms, and available PAM sites rather than simply applying a fixed positional rule.

Note: Avoiding the ATG start codon itself is not a universal requirement. In many knockout strategies, targeting sequences near the start codon can be effective if the resulting editing event is expected to disrupt the coding sequence.

3. Design Candidate sgRNAs

1. Candidate sgRNAs can be designed using online tools such as CRISPOR and CCTop, or through other validated CRISPR design platforms.

2. These tools typically evaluate candidate sgRNAs based on factors such as:

   • Predicted on-target activity

   • GC content

   • PAM compatibility

   • Potential off-target sites

   • Sequence context

   • Target specificity

3. Select candidate sgRNAs with high predicted on-target activity, high specificity, and minimal high-risk off-target sites for experimental validation.

4. Experimentally Validate sgRNA Activity

Predicted scores provide a useful starting point, but sgRNA performance should ultimately be validated experimentally.

Depending on the experimental system, sgRNA and Cas9 can be delivered into the target cells using methods such as plasmid transfection, mRNA delivery, or ribonucleoprotein (RNP) delivery.

Editing efficiency can then be evaluated using appropriate methods, such as:

• PCR and Sanger sequencing

• Amplicon sequencing

• T7E1 or related mismatch-based assays

• Next-generation sequencing (NGS)

For knockout studies, it is also important to confirm the functional consequence of editing, such as loss or reduction of the target protein, rather than relying solely on DNA-level editing efficiency.

III. Important Considerations

1. Minimize Off-Target Effects

Off-target activity is an important consideration in CRISPR experiments. Candidate sgRNAs should therefore be screened against the relevant genome to identify potential off-target sites.

Particular attention should be paid to predicted off-target sites located within coding regions or other functionally important genomic regions.

2. Consider Experimental Conditions

sgRNA activity can vary depending on the experimental system. Factors such as:

• Cell type

• Delivery method

• Cas9 expression level

• sgRNA expression

• Chromatin accessibility

• Target sequence context

may all influence editing efficiency.

Therefore, a highly ranked sgRNA in a computational prediction tool does not necessarily guarantee optimal performance in every cell type.

3. Design Multiple Candidate sgRNAs

For important genome-editing experiments, it is recommended to design multiple independent sgRNAs targeting the same gene.

Testing multiple candidates allows researchers to identify sgRNAs with optimal editing efficiency and specificity and provides additional support for attributing the observed phenotype to the intended genetic modification.

For particularly important functional studies, using two or more independent sgRNAs that produce similar phenotypes can further strengthen the experimental conclusions.

IV. Practical sgRNA Design Checklist

Before ordering or synthesizing an sgRNA, consider the following:

• Target length: Typically 20 nt for SpCas9

• PAM: Usually NGG for SpCas9

• GC content: Approximately 30%–70% as a general guideline

• Specificity: Minimize potential high-risk off-target sites

• Target region: Prefer functionally relevant regions appropriate for the experimental goal

• Transcript selection: Consider all relevant transcript isoforms

• Promoter compatibility: Check the requirements of the sgRNA expression system

• On-target activity: Compare predicted activity scores

• Experimental validation: Test multiple candidate sgRNAs whenever possible

• Functional validation: Confirm that genomic editing produces the intended biological effect

A well-designed sgRNA should therefore be selected based not on a single parameter, but on a combination of target accessibility, predicted activity, sequence specificity, transcript structure, and experimental validation.